Hearing loss in fabry disease: A 16 year follow-up study of the Danish nationwide cohort.

"Declaration of Competing Interest U·F-R. has received Advisory Board honoraria from Amicus Therapeutics, Freeline Therapeutics, 10.13039/100013995Sanofi Genzyme, and Takeda, speaker honoraria from Amicus Therapeutics, 10.13039/100013995Sanofi Genzyme, and Takeda, grant support from 10.13039/100007343Shire and 10.13039/100013995Sanofi Genzyme, and is a member of the European Advisory Board of the Fabry and FollwMe Registries."

"Ira Hagen Pedersen (Nurse), Anne Marie Jensen (Audiological technical officer), Erik Finn Kjærbøl (M.Sc. E. E.) and Casper Kok (laboratory technician) are thanked for excellent assistance. Members of the Fabry Team at Rigshospitalet are thanked for continuously supplying data. UFR's research salary was supported by the Kirsten and Freddy Johansen's Fund. The project was financially supported by 10.13039/100004339Sanofi-Genzyme."